1. Home
  2. MIST vs ABLV Comparison

MIST vs ABLV Comparison

Compare MIST & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • ABLV
  • Stock Information
  • Founded
  • MIST 2003
  • ABLV 2015
  • Country
  • MIST Canada
  • ABLV China
  • Employees
  • MIST N/A
  • ABLV N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • ABLV
  • Sector
  • MIST Health Care
  • ABLV
  • Exchange
  • MIST Nasdaq
  • ABLV Nasdaq
  • Market Cap
  • MIST 53.9M
  • ABLV 47.3M
  • IPO Year
  • MIST N/A
  • ABLV N/A
  • Fundamental
  • Price
  • MIST $1.62
  • ABLV $1.18
  • Analyst Decision
  • MIST Strong Buy
  • ABLV
  • Analyst Count
  • MIST 2
  • ABLV 0
  • Target Price
  • MIST $9.50
  • ABLV N/A
  • AVG Volume (30 Days)
  • MIST 994.4K
  • ABLV 12.2K
  • Earning Date
  • MIST 05-14-2025
  • ABLV 04-23-2025
  • Dividend Yield
  • MIST N/A
  • ABLV N/A
  • EPS Growth
  • MIST N/A
  • ABLV N/A
  • EPS
  • MIST N/A
  • ABLV N/A
  • Revenue
  • MIST N/A
  • ABLV $128,932,647.00
  • Revenue This Year
  • MIST N/A
  • ABLV N/A
  • Revenue Next Year
  • MIST N/A
  • ABLV N/A
  • P/E Ratio
  • MIST N/A
  • ABLV N/A
  • Revenue Growth
  • MIST N/A
  • ABLV N/A
  • 52 Week Low
  • MIST $0.63
  • ABLV $0.55
  • 52 Week High
  • MIST $2.75
  • ABLV $1.90
  • Technical
  • Relative Strength Index (RSI)
  • MIST 60.67
  • ABLV 51.69
  • Support Level
  • MIST $1.39
  • ABLV $0.97
  • Resistance Level
  • MIST $1.60
  • ABLV $1.16
  • Average True Range (ATR)
  • MIST 0.11
  • ABLV 0.11
  • MACD
  • MIST 0.03
  • ABLV -0.02
  • Stochastic Oscillator
  • MIST 86.60
  • ABLV 47.25

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: